Investors Hangout Stock Message Boards Logo
  • Home
  • Mailbox
  • Boards
  • Favorites
  • Whats Hot!
  • Login - Join Now!
Profile
investorxc's Profile
Displaying 1-50 of 343 result(s).
AMBS Amarantus Bioscience Holdings
10/25/2019 12:38:50 PM
"Pursuant to the agreement, upon ce (1)
AMBS Amarantus Bioscience Holdings
10/25/2019 11:28:54 AM
I sold my shares in this stock some
AMBS Amarantus Bioscience Holdings
05/28/2019 8:30:15 PM
As I've posted before I think is li
AMBS Amarantus Bioscience Holdings
05/10/2019 11:00:57 AM
I'm really surprised they revoked t (1)
AMBS Amarantus Bioscience Holdings
05/10/2019 10:51:50 AM
Avant just had their stock registra (1)
AMBS Amarantus Bioscience Holdings
04/14/2019 6:46:40 PM
The 7.5 million shares of Coeptis i (1)
AMBS Amarantus Bioscience Holdings
04/04/2019 5:16:43 PM
Coeptis was supposed to raise $6 mi (1)
AMBS Amarantus Bioscience Holdings
04/03/2019 11:47:01 AM
I think it’s very possible that A
AMBS Amarantus Bioscience Holdings
03/28/2019 1:37:08 AM
https://www.digitalmusicnews.com/2
AMBS Amarantus Bioscience Holdings
03/28/2019 1:34:00 AM
https://www.google.com/amp/s/www.b
AMBS Amarantus Bioscience Holdings
03/08/2019 1:23:12 PM
Avant has filed their annual report
AMBS Amarantus Bioscience Holdings
01/22/2019 5:33:59 PM
Gerald is definitely making plans f
AMBS Amarantus Bioscience Holdings
01/18/2019 1:06:15 PM
We are now showing as being current (1)
AMBS Amarantus Bioscience Holdings
01/16/2019 12:11:21 PM
They are all caught up now on the f (1)
AMBS Amarantus Bioscience Holdings
01/07/2019 10:36:59 PM
I went back and read the pr again:
AMBS Amarantus Bioscience Holdings
01/07/2019 10:13:52 PM
I think it's very possible that Cha
AMBS Amarantus Bioscience Holdings
01/07/2019 11:45:14 AM
The big news today is that Gerald i (6)
AMBS Amarantus Bioscience Holdings
01/03/2019 11:48:50 AM
Avant just filed their 10Q for 4th
AMBS Amarantus Bioscience Holdings
01/03/2019 11:37:40 AM
MER was also an Israeli company. (1)
AMBS Amarantus Bioscience Holdings
01/02/2019 12:03:47 PM
There is a bid now for 1.8 million
AMBS Amarantus Bioscience Holdings
12/29/2018 12:41:48 PM
The note holders extended as I had (1)
AMBS Amarantus Bioscience Holdings
12/13/2018 12:46:36 PM
Avant filed their 10K for fiscal ye (1)
AMBS Amarantus Bioscience Holdings
12/09/2018 5:47:01 PM
As I've been saying all along, I th (4)
AMBS Amarantus Bioscience Holdings
11/30/2018 8:39:53 PM
I will make a prediction. I think w (1)
AMBS Amarantus Bioscience Holdings
11/29/2018 11:30:29 AM
Kadmon wasn't acquired by Eli Lilly (1)
AMBS Amarantus Bioscience Holdings
11/28/2018 7:38:13 PM
I would not be surprised if this co
AMBS Amarantus Bioscience Holdings
11/28/2018 1:19:21 PM
$18 million is an awful lot of mone
AMBS Amarantus Bioscience Holdings
11/28/2018 12:26:37 PM
Coeptis just filed a form D. It loo (1)
AMBS Amarantus Bioscience Holdings
11/28/2018 12:05:28 PM
Dave Mehalick, the CEO of Coeptis h (1)
AMBS Amarantus Bioscience Holdings
11/28/2018 11:29:06 AM
This press release was released by
AMBS Amarantus Bioscience Holdings
11/26/2018 12:36:53 PM
There has been a pretty big increas (3)
AMBS Amarantus Bioscience Holdings
11/07/2018 9:25:44 PM
I stopped being shocked about 2 yea (6)
AMBS Amarantus Bioscience Holdings
11/07/2018 2:50:56 PM
MTSL has definitely been a target f (1)
AMBS Amarantus Bioscience Holdings
11/05/2018 1:15:52 PM
The point of doing the merger is to
AMBS Amarantus Bioscience Holdings
11/05/2018 11:47:23 AM
Nothing has changed in the amendmen (4)
AMBS Amarantus Bioscience Holdings
11/01/2018 9:05:10 AM
I think you're right. They entered
AMBS Amarantus Bioscience Holdings
10/31/2018 11:23:49 PM
It looks like the ESS deal with MER (1)
AMBS Amarantus Bioscience Holdings
10/31/2018 11:21:17 PM
It looks like they are giving Psych
AMBS Amarantus Bioscience Holdings
10/31/2018 10:53:05 PM
Quarterly report is out! https://ww
AMBS Amarantus Bioscience Holdings
10/30/2018 10:45:14 PM
To clarify my earlier post, I meant
AMBS Amarantus Bioscience Holdings
10/29/2018 3:29:11 PM
I think there is still a very real (1)
AMBS Amarantus Bioscience Holdings
10/26/2018 2:53:41 PM
Last Thursday Amarantus submitted t (1)
AMBS Amarantus Bioscience Holdings
10/25/2018 10:27:29 AM
Roger Challen pulled his support fo
AMBS Amarantus Bioscience Holdings
10/24/2018 7:22:48 PM
More specifically, I think the inve
AMBS Amarantus Bioscience Holdings
10/24/2018 6:58:41 PM
But the question is why put out a p (2)
AMBS Amarantus Bioscience Holdings
10/24/2018 6:35:40 PM
What's interesting is the offer was (2)
AMBS Amarantus Bioscience Holdings
10/24/2018 6:11:55 PM
Offer for jv was just withdrawn- un
AMBS Amarantus Bioscience Holdings
10/23/2018 8:47:53 PM
That makes sense as to why they wou
AMBS Amarantus Bioscience Holdings
10/23/2018 8:24:22 PM
It’s definitely strange for them
AMBS Amarantus Bioscience Holdings
10/21/2018 7:14:52 PM
The trading activity on MTSL is ver (1)
Go to page:
  • << First
  • < Previous
  • 1
  • 2
  • Next >

Recent Articles

  • AMD's Upcoming Investor Conferences and Participation Insights
  • Microbot Medical’s LIBERTY® System Set for First Showcase Event
  • Connecting Families During the Holidays: The Guidepost Co. Experience
  • Xenon Pharmaceuticals Welcomes Tucker Kelly as CFO
  • Culture Discovery Vacations: Innovative Approach to Travel Success
  • Comfort Colors® Marks 50 Years with Unforgettable Game Day Fun
  • Empowering Small Businesses Through Public Market Access
  • Saltbox Expands Leadership with Katerina Cirilli as Co-CEO
  • FTI Consulting Expands Financial Services Leadership Team
  • Understanding the New Divorce Financial Analysis Guide
  • Runway Growth Finance Corp. Prepares for Q3 Financial Results
  • PAJUNK Unveils Major Expansion at Its U.S. Headquarters
  • Stay Safe This Halloween: Tips to Avoid Train Accidents
  • Global Companies Unite for Climate Action Ahead of COP30
  • BridGene Biosciences Secures $28 Million for Drug Development
  • US Investment Surge: Scott Bessent Highlights Sustainability
  • Exploring Key Trends in Fortune 500 Security Design
  • TANAKA Growth Fund Scores Impressive #2 Lipper Ranking
  • United Airlines Enhances Travel with Starlink Wi-Fi Experience
  • Equity Union Real Estate Achieves Remarkable Growth Milestone
  • Investors Eye BlackRock and Teradyne: Insights and Trades
  • Principled Transformation Earns Top Recognition for Workplace Culture
  • OPSWAT Partners with NetApp to Enhance File Security Solutions
  • CYRIN Unleashes Advanced Container Solutions for Cybersecurity
  • Wipro's Revenue Growth and Strategic Future Plans Ahead
  • CloudX to Share Insights at Exclusive AI Leadership Summit
  • Exciting Developments in Parkinson's Cell Therapy with UX-DA001
  • Workflow Services Introduces ECAPS Watch Podcast and Whitepaper
  • Global Mobility Solutions Boosts Relocation Services with AI
  • Dagnee Strengthens Advisory Board with Perry Solomon's Expertise
  • Algenesis Labs and Safic-Alcan Team Up for Eco-Friendly Innovation
  • Cantrell Law Firm Enhances Services with New Appointment
  • ZOOZ Enhances Bitcoin Holdings, Reaching 942 Digital Assets
  • NANO Nuclear Energy Sets Stage for Upcoming Investor Conferences
  • Fitell Corporation Achieves Nasdaq Compliance with Shares
  • Primech Holdings and GAIB Forge Innovative Partnership for AI Revenue
  • Strategic CDO Appointment Enhances House of Doge's Vision
  • Odyssey Health Expands Horizons in Breast Medical Technology
  • Cloudastructure, Inc. Launches $5 Million Share Buyback Initiative
  • AmpliTech Group Set to Shine at 2025 Growth Summit Event
  • Chartwell Shares Insights on Growth Strategies and Finance Progress
  • Cannabix Technologies Delivers BreathLogix to Improve Safety
  • Brixmor Property Group's CEO Steps Down for Medical Leave
  • Climb Global Solutions Announces Upcoming Q3 2025 Call Details
  • Investing in Pediatric Mental Health: Triplemoon's Growth Journey
  • Fluent's Rebuy Monetize Partnership Elevates Merchant Success
  • Avanti Helium Concludes Successful Private Placement Efforts
  • Discovering High-Grade Gold Potential at Reforma Mine
  • Aligos Therapeutics Announces Generic Name Approval for Drug ALG-000184
  • Cascadia's Successful Completion of Carmacks Drill Program
  • Home - Investors HangoutHome

  • Mailbox - Investors HangoutMailbox

  • Boards - Investors HangoutBoards

  • Favorites - Investors HangoutFavorites

  • Whats Hot! - Investors HangoutWhats Hot!

  • More - Investors HangoutMore

  • Settings - Investors HangoutSettings
  • Login - Investors HangoutLogin
  • Live Site - Investors HangoutLive Site